Clinical Trial Update: A Study of Ziprasidone for the Treatment of Psychosis in Patients Who Had Already Had Benefits From Ziprasidone Treatment in a Previous Study [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating ziprasidone for psychosis in patients previously benefited from ziprasidone treatment; status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorders

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Pyschotic Disorders | Phase 4 | Status: COMPLETED